Skip to main navigation
Close
Menu
Main navigation
Advocacy
Issue Overview
#Rx4StateSavings
#4GRxANTED
#MarkupMadness
State Advocacy
GDUFA/BsUFA User Fees
Biosimilars Council
Action Center
Our Impact
Join
About Us
Generic Quality
About AAM
Our Team
Our Members
Generic Medicines
Biosimilars Council
Meet Our Board
Social Commitment
Careers
Contact Us
Stories
Events
Resources
All Resources
Drug Shortages White Paper
2023 Savings Report
Biosimilars Patient Resource Center
Biosimilar Research & Studies
Press Releases
Blog
Founders Blogs
Amicus Briefs
Take Action
Breadcrumb
Association for Accessible Medicines
Resources
Resources
Share
Find up-to-date information on generics and biosimilars
Filter Resources
Issues
Biosimilar User Fee Act (BsUFA)
Biosimilars
Complex Generics
Drug Approval Process (GDUFA)
Drug Prices
Drug Shortages
Generic Drug Labeling
Generic Supply Chain
IP Issues
Low Income Subsidies (LIS in Part D)
Medicaid
Medicare
NAFTA
Patent Reform
Patient Stories
Pharmaceutical Waste Take Back
Preventing Drug Abuse
Quality
REMS/Sample Acquisition Remedies
State Initiatives
Tariffs
Trade
Transparency
User Fees
Resource Type
Blog
Amicus Brief
Press Release
Infographic
Video
Report
Fact Sheet
Presentation
Blog
Mar 28, 2018
| Erica Klinger
Skyrocketing Drug Prices: What's Driving Up Costs?
Infographic
Mar 26, 2018
| Erica Klinger
Skyrocketing Drug Prices Are a Threat to Everyone
Fact Sheet
Mar 23, 2018
| Erica Klinger
Oppose Maryland House Bill 1194 & Senate Bill 1023
Press Release
Mar 20, 2018
| Rachel Schwartz
AAM Statement — Restricting Patent Settlements Hurts Patients
Press Release
Mar 16, 2018
| Rachel Schwartz
Op-Ed from STAT — Grassley, Leahy: It's Time to Empower Generic Drug Makers to Bring Down Prices
Video
Mar 13, 2018
| Erica Klinger
The CREATES Act - A Conservative Market-based Solution to Lower Drug Prices
Fact Sheet
Mar 9, 2018
| Erica Klinger
AAM Issue Brief: Inter Partes Review (IPR)
Press Release
Mar 8, 2018
| Rachel Schwartz
AAM Statement on PACED Act of 2018
Fact Sheet
Mar 5, 2018
| Erica Klinger
AAM Issue Brief: Biosimilars Medicare Part B
Fact Sheet
Feb 28, 2018
| Rachel Schwartz
AAM Position Paper: HHS 180-Day Exclusivity Proposal
Blog
Feb 28, 2018
| Rachel Schwartz
Recap of Access! 2018 — Delivering on the Promise of Generics and Biosimilars (Part 3)
Fact Sheet
Feb 28, 2018
| Erica Klinger
Oppose Colorado House Bill 1179
Load More
Advocacy
Issue Overview
#Rx4StateSavings
#4GRxANTED
#MarkupMadness
State Advocacy
GDUFA/BsUFA User Fees
Biosimilars Council
Action Center
Our Impact
Join
About Us
Generic Quality
About AAM
Our Team
Our Members
Generic Medicines
Biosimilars Council
Meet Our Board
Social Commitment
Careers
Contact Us
Stories
Events
Access! 2024
GRx+Biosims 2023
Resources
All Resources
Drug Shortages White Paper
2023 Savings Report
Biosimilars Patient Resource Center
Biosimilar Research & Studies
Press Releases
Blog
Founders Blogs
Amicus Briefs
Take Action